The rhodium(III)-catalyzed asymmetric allylic cyclization of cyclohexadienone-tethered allenes is successfully developed. This protocol exhibits broad functional group tolerance and is applicable for modifying biologically active molecules containing phenol structures. Notably, compounds 3ga and 3ha demonstrate promising anticancer properties.
J. Zhang, D. Shi, P. Tian and Q. Li, Org. Biomol. Chem., 2025, 23, 3643 DOI: 10.1039/D5OB00220F
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Please wait while we load your content...
